Glenmark Pharmaceuticals Inc., USA is recalling approximately 322,470 bottles of Potassium Chloride Extended-Release Capsules, USP, 750 mg (10 mEq K). The recall includes both 100-count and 500-count bottles. This recall was initiated due to the product failing dissolution specifications and manufacturing quality (CGMP) deviations discovered during testing.
Failed dissolution specifications mean the medication may not release properly in the body. This could result in the medication being ineffective for treating low potassium levels or, conversely, a sudden release of the drug that could lead to an overdose.
You have 2 options:

Label, Glenmark Potassium Chloride Extended Release 750mg Capsules, 100 count

Label, Glenmark Potassium Chloride Extended Release 750mg Capsules, 500 count
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท FDA Press Release ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.